Intrepid Investment Bankers Advises on Growth Equity Investment in Envy Medical, Inc.

Intrepid Investment Bankers announced today its advisory role in the recent growth equity investment in Envy Medical, Inc. by HCP & Company.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
This is the first time in Envy’s history that we have taken on outside growth capital, and we did so with unanimous board and shareholder support.

Los Angeles, Calif. (PRWEB) June 16, 2014

Intrepid Investment Bankers (Intrepid), a leading middle-market investment bank and an active M&A advisor in the beauty care sector, announced today its advisory role in the recent growth equity investment in Envy Medical, Inc. by HCP & Company (HCP).

Envy Medical, a leader in the professional skincare products and services space, develops, markets and sells highly-effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. HCP is a Chicago-based private equity firm specializing in growth equity and buyout investments, with approximately $215 million in assets under management. The new funding will support sales and marketing initiatives, while also allowing Envy Medical to accelerate the development and introduction of exciting new skincare offerings designed to meet the growing demand for healthier skin tone, texture and function.

“Intrepid had a great understanding of our company needs and found us the right partner. This is the first time in Envy’s history that we have taken on outside growth capital, and we did so with unanimous board and shareholder support,” said Curtis A. Cluff, Chief Executive Officer of Envy Medical. “That support is due in large part to HCP’s business acumen and an understanding that they bring significant experience to the table as Envy accelerates growth towards becoming a major global player in the specialized skincare market.” “This is an exciting time for the company,” said Ken Karasiuk, Envy Medical Founder and Chairman of the Board.

“We were thrilled to play a role in the growth of Envy Medical. We have a tremendous amount of respect for and belief in the Envy Medical team and the platform they are building,” said Steve Davis, Managing Director and Head of the Beauty & Personal Care Practice at Intrepid. “We look forward to seeing what Envy Medical can accomplish with this capital investment and partnership with HCP.”

For further information on the transaction, please contact Steve Davis, Managing Director and Head of the Beauty & Personal Care Practice at Intrepid, at 310-478-9000 or SDavis(at)IntrepidIB(dot)com.

About Intrepid Investment Bankers
Intrepid Investment Bankers is a specialty investment bank that provides M&A, capital raising and strategic advisory services to middle-market companies across various industry sectors. We have a unique culture rooted in our founders’ successful 30-year history of advising entrepreneur and family-owned businesses, financial sponsors and major corporations. We believe that every company has an entrepreneurial passion that drives it and a story that defines it. We deliver unconventional results through our unique ability to tell each client’s story, and drive relentless execution through senior banker immersion in each process. We augment our international capabilities through our membership and active participation in M&A International Inc., an exclusive global alliance of select independent middle-market M&A advisory firms. Member FINRA/SIPC.


Contact

Attachments